Taken together, our findings indicate that RGE enhances the abundance of CD8+ T cell infiltration on hPD-L1 MC38 tumors and showed greater antitumor activity in the hPD-1/hPD-L1 knock-in MC38 CRC tumor allograft mouse model. This evidence concerns the gene CD8A and colorectal carcinoma.